Table 1.
Study Demographics and Clinical Characteristics
| High Tumor CcO Activity (N = 68) | Low Tumor CcO Activity (N = 84) | Total (N = 152) | P-value | |
|---|---|---|---|---|
| Gender | ||||
| Male | 38 (55.9%) | 41 (48.8%) | 79 (52%) | .42 |
| Female | 30 (44.1%) | 43 (51.2%) | 73 (48%) | |
| Ethnicity | ||||
| Hispanic or Latino | 4 (7.4%) | 9 (13.0%) | 13 (10.6%) | .38 |
| Non-Hispanic or Latino | 50 (92.6%) | 60 (87.0%) | 110 (89.4%) | |
| Unknown/not reported | 14 | 15 | 29 | |
| Race | ||||
| White | 50 (87.7%) | 61 (89.7%) | 111 (88.8%) | .78 |
| Non-White | 7 (12.3%) | 7 (10.3%) | 14 (11.2%) | |
| Unknown/not reported | 11 | 16 | 27 | |
| Receipt of SOC | ||||
| Yes | 60 (88.2%) | 78 (92.9%) | 138 (90.7%) | .40 |
| No | 8 (11.8%) | 6 (7.1%) | 14 (9.2%) | |
| MGMT status-methylateda | 11 (19%) | 22 (32%) | .15 | |
| Height (cm)b | 169 (10.5) | 170 (10.5) | .59 | |
| Weight (kg) | 82 (16.2) | 86 (21.8) | .21 | |
| Age at surgery | 61 (11.6) | 61 (10.8) | .85 | |
| Karnofsky score | 82 (11.4) | 82 (9.5) | .85 |
Abbreviations: CcO, cytochrome C oxidase; SOC, standard of care.
a MGMT status was “undetermined” for 26 participants.
bHeight missing for 1 participant.